Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, val…
Medical - Care Facilities
US, Alhambra [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -18.54 | 30.09 | 36.94 | |
| Graham Fair Price | 33.94 | 11.66 | 8.71 | |
| PEG | -91.77 | 0.24 | -2.92 | |
| Price/Book | -7.89 | 2.42 | 2.63 | |
| Price/Cash Flow | 99.09 | 127.08 | 63.83 | |
| Prices/Earnings | -42.32 | 16.27 | 28.21 | |
| Price/Sales | -3.38 | 4.12 | 4.27 | |
| Price/FCF | 99.09 | 127.08 | 63.83 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Somewhat Weak
Fundamentals
Profitability
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 31.58 | 0.21 | 0.16 | |
| Operating Margin | 44.61 | 0.11 | 0.08 | |
| ROA | 60.30 | 0.02 | 0.01 | |
| ROE | 0.02 | 0.04 | 59.68 | |
| ROIC | 0.02 | 0.03 | 83.42 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.02 | < 0.005 | 220.08 | |
| Dividends QOQ | 5.03 | 0.97 | -80.74 | |
| EBIT QOQ | 0.21 | 0.45 | 114.30 | |
| EPS QOQ | -0.10 | 0.68 | 601.19 | |
| FCF QOQ | 4.27 | -0.51 | -87.93 | |
| Revenue QOQ | 0.04 | < 0.005 | -99.72 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 0.11 | 0.00 | inf | |
| Days Sales Outstanding (DSO) | 39.27 | 47.90 | 21.99 | |
| Inventory Turnover | 848.92 | 0.00 | inf | |
| Debt/Capitalization | 0.29 | 0.28 | -1.78 | |
| Quick Ratio | 2.43 | 2.28 | -6.25 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q2 | Q3 | Δ in % | |
|---|---|---|---|---|
| Book Value | 12.03 | 12.76 | 5.99 | |
| Cash | 6.33 | 5.95 | -5.99 | |
| Capex | -0.05 | -0.09 | -64.87 | |
| Free Cash Flow | 0.50 | 0.24 | -50.96 | |
| Revenue | 7.40 | 7.48 | 1.04 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad